Related Experiment Video

Updated: Apr 4, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K

Preventive strategies against brain metastases: current state of the art and future directions

Franziska Maria Ippen1,2, Franz Felix Konen3, Peter Hau4

  • 1Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. Franziska.Ippen@med.uni-heidelberg.de.

Neurological Research and Practice
|April 3, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Brain metastasesCancer neurosciencePreventionPreventive strategies

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.5K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

8.3K

Related Experiment Videos

Last Updated: Apr 4, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.5K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

8.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K

Articles linked to this work by shared authors, journal, and citation graph.

Cancer Neuroscience: Establishing a home in Neuro-Oncology.

Neuro-oncology·2026

Memory, social cognition, and beyond: Neuropsychological markers differentiating Alzheimer's disease and frontotemporal dementia.

Journal of Alzheimer's disease : JAD·2026

Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis.

Neuro-oncology advances·2026

Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).

European journal of cancer (Oxford, England : 1990)·2026

Survival of primary brain tumor patients according to treatment in certified oncologic centers.

Cancer treatment and research communications·2026

Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany.

EClinicalMedicine·2026

Proportionate and disproportionate reporting of different infectious complications of disease modifying therapy in multiple sclerosis.

Neurological research and practice·2026

Stroke-associated pneumonia: from immunodepression to bedside management and future research directions.

Neurological research and practice·2026

Atrial fibrillation in stroke patients: facts, numbers and current challenges.

Neurological research and practice·2026

FXI and FXII in experimental stroke and FXI in clinical stroke trials.

Neurological research and practice·2026

Post-transfer reassessment for endovascular treatment: factors associated with changes in EVT eligibility.

Neurological research and practice·2026

Deep brain stimulation for arm tremor: one-year blinded follow-up of a randomized trial.

Neurological research and practice·2026

Calcineurin-mediated regulation of macrophage plasticity drives anti-tumor activity.

Molecular therapy. Advances·2026

EXO1 inhibition selectively kills replication repair-deficient cancer cells.

NAR cancer·2026

Biotics-based modulation of gastric precancerous states: microbial, metabolic, and epithelial mechanisms.

Frontiers in immunology·2026

Pan-cancer biomarkers of immune therapy resistance: mechanisms and clinical translation.

Frontiers in cell and developmental biology·2026

DYRK1A - a gene dose paradox.

Frontiers in cell and developmental biology·2026

Visualizing the distribution of durvalumab targeting PD-L1 using quantitative fluorescence imaging in patients with esophageal cancer.

Theranostics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us